LAPORTE KATHLEEN
SEC insider (Form 3/4/5 filer). CIK 0001196201. Director at Q32 Bio Inc. (QTTB) and 4 other issuers. 64 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in WALTHAM, MA.
Companies LAPORTE KATHLEEN has filed insider reports for
- Q32 Bio Inc. (QTTB): Director
- Bolt Biotherapeutics, Inc. (BOLT): Director
- Precipio, Inc. (PRPO): Director
- CERO THERAPEUTICS HOLDINGS, INC. (CERO): Director
- 89bio, Inc. (ETNB): Director
LAPORTE KATHLEEN
CIK: 0001196201
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (64 total)
- Jun 12, 2026QTTB
Q32 Bio Inc.
AwardDirectStock Option (Right to Buy)
10.8K shares- - Jun 12, 2026QTTB
Q32 Bio Inc.
AwardDirectStock Option (Right to Buy)
9.8K shares- - Jun 10, 2026BOLT
Bolt Biotherapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5K shares- - Jan 15, 2026QTTB
Q32 Bio Inc.
AwardDirectStock Option (Right to Buy)
23.3K shares at avg. $2.75- - Jan 15, 2026PRPO
Precipio, Inc.
AwardDirect520 shares at avg. $24.00$12K - Jan 7, 2026CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
690.9K shares- - Jan 2, 2026PRPO
Precipio, Inc.
AwardDirectStock Option (Right to Buy)
1.5K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
1.4K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
DispositionDirectDirector Stock Option (Right to Buy)
1.4K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
1.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  QTTB Q32 Bio Inc. | Award Stock Option (Right to Buy) | 10,826 | - | - | Direct |
| Jun 12, 2026 | QTTB Q32 Bio Inc. | Award Stock Option (Right to Buy) | 9,810 | - | - | Direct |
| Jun 10, 2026 |  BOLT Bolt Biotherapeutics, Inc. | Award Stock Option (Right to Buy) | 5,000 | - | - | Direct |
| Jan 15, 2026 | QTTB Q32 Bio Inc. | Award Stock Option (Right to Buy) | 23,272 | $2.75 | - | Direct |
| Jan 15, 2026 |  PRPO Precipio, Inc. | Award | 520 | $24.00 | $12,480 | Direct |
| Jan 7, 2026 |  CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 690,900 | - | - | Direct |
| Jan 2, 2026 | PRPO Precipio, Inc. | Award Stock Option (Right to Buy) | 1,500 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award Director Stock Option (Right to Buy) | 1,392 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition Director Stock Option (Right to Buy) | 1,392 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
1-10 of 64 transactions